Post-approval studies (Phase 4)UnknownNCT05580354
What this trial is testing
Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer
Who this might be right for
Non-muscle-invasive Bladder Cancer
Ruijin Hospital 42